HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

tris(2,2-dimethyl-1-aziridinyl)phosphine oxide

an alkylating agent, , was chosen for clinical trial because of its superior performance in animal tumor systems

Also Known As:

TEPA-132

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azirines
    - Aziridines: 14
      - tris(2,2-dimethyl-1-aziridinyl)phosphine oxide: 1
Inorganic Chemicals: 9
- Phosphorus Compounds: 84
  - Phosphines: 18
    - tris(2,2-dimethyl-1-aziridinyl)phosphine oxide: 1
Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Phosphines: 18
    - tris(2,2-dimethyl-1-aziridinyl)phosphine oxide: 1

Related Diseases

1.	Neoplasms (Cancer) 06/01/1972 - "Tris(2,2-dimethyl-1-aziridinyl)phosphine oxide (TEPA-132), an alkylating agent, was chosen for clinical trial because of its superior performance in animal tumor systems. "

Related Drugs and Biologics

1.	Alkylating Agents